ArticleOpen forum infectious diseases2026
Minimally Invasive Tissue Sampling for Postmortem Diagnosis of Tuberculous Meningitis in Zambian Adults.
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Background: The true burden of tuberculous meningitis (TBM), particularly in low and middle-income countries, is unknown due to imperfect diagnostics. Complete diagnostic autopsy (CDA) to confirm TBM in deceased meningitis patients is uncommon. Minimally invasive tissue sampling (MITS) has been shown to be a viable alternative to CDA to establish infectious etiologies of meningitis. We used MITS to determine the burden of TBM among deceased adult Zambians who presented with meningitis. Methods: We performed a prospective cohort study of Zambian adults who presented with symptoms suggestive of TBM, recording whether they had a complete cerebrospinal fluid (CSF) diagnostic assessments during their admission. We followed patients for the outcome of discharge or death. Among those who died, after obtaining consent from the family, we performed MITS, collecting CSF, brain, lung, and liver tissue looking for evidence of Results: We completed MITS on 50 deceased Zambian adults who presented with meningitis symptoms. Twenty-two cases had a complete antemortem CSF evaluation. Among these cases, 4/22 (18%) were diagnosed with TBM before death and an additional 2/22 (9%) were diagnosed with TBM via MITS after death. Twenty-eight deaths occurred in patients with an incomplete or no CSF evaluation. Among these cases, 4/28 (14%) were diagnosed with TBM via MITS. Conclusions: MITS can confirm the diagnosis of TBM in deceased meningitis patients. It can be a valuable tool in meningitis surveillance to establish an infectious etiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.